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PURPOSE. To investigate the clinical and mitochondrial DNA (mtDNA) haplogroup background
of Indian Leber hereditary optic neuropathy (LHON) patients carrying the m.14484T>C
mutation.
METHODS. Detailed clinical investigation and complete mtDNA sequencing analysis was
carried out for eight Indian LHON families with the m.14484T>C mutation. Haplogroup was
constructed based on the evolutionarily important mtDNA variants.
RESULTS. In the present study, we characterized eight unrelated probands selected from 187
LHON cases. The overall penetrance of the disease was estimated to be 19.75% (16/81) in
eight pedigrees with the m.14484T>C mutation and showed substantially higher sex bias
(male:female ¼ 13:3). The mtDNA haplogrouping revealed that they belong to diverse
haplogroups; i.e., F1c1, M31a, U2a, M*, I1, M6, M3a1, and R30a. Interestingly, we did not find
an association of the m.14484T>C mutation with any specific haplogroup within the Indian
population. We also did not find any secondary mutation(s) in these pedigrees, which might
affect the clinical expression of LHON.
CONCLUSIONS. Contrary to earlier reports showing preferential association of the m.14484T>C
mutation with western Eurasian haplogroup J and increased clinical penetrance when present
in J1 subhaplogroup background, the present study shows that m.14484T>C arose
independently in a different mtDNA haplogroup and ethnic background in India, which
may influence the clinical expression of the disease.
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Mitochondrial DNA (mtDNA) mutations have been reportedto cause a large number of genetic disorders.1,2 During the
last two decades there has been major progress in identification
of disease-causing mtDNA mutations. Leber hereditary optic
neuropathy (LHON, OMIM 535000) is one of the first diseases
to be characterized primarily by the missense mutations in
mtDNA. LHON is a maternally inherited disorder clinically
characterized as a slow and progressive loss of central vision
due to degeneration of the optic nerve and retinal ganglion
cells in young adults, predominantly affecting males.3–5
Mutations in different subunits of mitochondrial complex I
genes (m.3460G>A in MT-ND1, m.11778G>A in MT-ND4, and
m.14484T>C in MT-ND6) have been reported in more than
95% of LHON cases across the world.6–8 A number of other
mutations have been reported in complex I genes in the
pedigrees negative for the three primary mutations.9 However,
the phenotypic expression of these primary mutations have
been found to vary in different families and even in different
populations, with only one-third of all individuals inheriting
these mutations developing visual failure or blindness. This
incomplete penetrance in different pedigrees suggests that
other factors, such as mtDNA haplogroup background, nuclear
genetic background, and environmental factors, may have an
important role in modulating the phenotypic expression and
severity of the disease.10–14 In addition to the primary
mutations, many other mtDNA sequence variants have been
reported along with the primary LHON mutations, suggesting
that these variants have possible synergistic roles in modulating
clinical expression.15–18
Various studies performed on LHON suggest that the
primary mutations m.11778G>A and m.14484T>C are strongly
associated with western Eurasian haplogroup J.18–21 These
observations also implicate the involvement of other J
haplogroup defining mutat ions (m.4216T>C and
m.13708G>A) in increasing the risk of disease expression.19
Further studies on pooled European LHON samples showed
Copyright 2013 The Association for Research in Vision and Ophthalmology, Inc.
www.iovs.org j ISSN: 1552-5783 3999
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933468/ on 05/16/2017
that the haplogroups J1, J2, and K increase the risk of vision
loss in LHON patients with m.14484T>C, m.11778G>A, and
m.3640G>A mutations, respectively, while haplogroup H has
been found to have a protective role for LHON patients with
the m.11778G>A mutation.10 These findings about LHON in
association with haplogroups have led to a substantial increase
in the number of studies to unravel the role of mtDNA
sequence variations in various disorders and phenotypes.
However, other than LHON, most of the reports showing
association between haplogroups and diseases remain provi-
sional. Most of the mtDNA haplogroup association studies have
given conflicting results in different populations because the
findings of one study have rarely been replicated by studies in
other populations.22
Studies on the m.14484T>C mutation in a European
population showed that more than 75% of LHON patients
belonged to haplogroup J,18 while another study showed low
penetrance of LHON when present in non–J haplogroup
background.17 Subsequently, a study by Hudson et al.10 in a
European population showed increased penetrance of the
disease when present in a J haplogroup background, specifi-
cally in the J1 subhaplogroup. Another study with French
Canadian LHON patients revealed that the m.14484T>C
mutation is predominantly associated with the LHON pheno-
type.23,24 However, studies on Asian families with this
mutation did not show a similar pattern of association with
any specific haplogroup.25,26 Until now there was only one
study from India, which reported three individuals with the
m.14484T>C mutation; however, the haplogroup of these
individuals was not established.27 Hence, we have character-
ized 8 out of 187 suspected Indian LHON families carrying the
primary m.14484T>C mutation to study the clinical, genetic,
and phylogenetic background of m.14484T>C positive indi-
viduals in the Indian population.
MATERIALS AND METHODS
Patients and Subjects
We screened a total of 187 individuals with LHON for
pathogenic mutations and found eight families carrying the
primary mutation m.14484T>C. These cases were collected
over a period of 7 years at the Sankara Nethralaya Eye Hospital,
Chennai, India; National Institute of Mental Health and Neuro
Sciences (NIMHANS), Bengaluru, India; and Nizam’s Institute
of Medical Sciences (NIMS), Hyderabad, India. Clinical
examinations were conducted in all patients and assessed
presentation of primary features including acute, gradual, and
progressive loss of central vision; color vision defect; and
centrocecal scotomas. All patients also underwent complete
ophthalmic examination, including evaluation by Snellen chart,
visual acuity measurement, slit lamp biomicroscopy, indirect
ophthalmology, and Humphrey perimetry analysis. Visual field
testing was performed in all patients with good fixation.
The degree of visual impairment was defined according to
the visual acuity as follows: normal > 0.3, mild ¼ 0.3 to 0.1;
moderate < 0.1 to 0.05 and severe < 0.05 to 0.02. Informed
written consent was obtained prior to sample collection from
all individuals who participated in this study. The study
adhered to the tenets of the Declaration of Helsinki and was
approved by Institutional Ethical Committees (IECs) of all the
participating institutions.
Genetic Analysis
Genomic DNA was extracted from peripheral blood samples
using a standard protocol.28 Overlapping DNA fragments to
cover the entire mtDNA were amplified using 24 sets of
primers.29,30 The overlapping amplicons were directly se-
quenced (both forward and reverse, separately) using the
BigDye Terminator cycle sequencing kit (Applied Biosystems,
Foster City, CA). Extended products were precipitated with
ethanol and 5 M sodium acetate (5:1) and then dissolved in Hi-
Di formamide and analyzed in ABI 3730 DNA Analyzer (Applied
Biosystems). All 48 sequences (24 forward and 24 reverse)
were edited using Sequence Analysis and assembled with the
rev i sed C ambr idge Re fe ren ce Se qu e nce ( rCRS ;
NC_012920)31,32 using AutoAssembler software (Applied
Biosystems). Quantification of the m.14484T>C mutation
was done by PCR restriction fragment length polymorphism
analysis (RFLP) as described earlier.33 The mtDNA sequence of
eight patients included in this study has been submitted to
GenBank with the following accession numbers: P18
(JX462682), P24 (JX462688), P26 (JX462690), P33
(JX462697), P35 (JX462699), P41 (JX462705), P48
(JX462712), and P51 (JX46271).
Data Analysis
All mismatched nucleotides along with their position were
noted and searched in human mitochondrial genome databases
such as Mitomap (http://www.mitomap.org), mtDB (http://
www.genpat.uu.se/mtDB), and HmtDB (http://www.hmtdb.
uniba.it:8080/hmdb) for their significance. The data obtained
were also compared with 300 ethnically matched control
samples from endogamous Indian populations. Haplogroup
was constructed based on the available literature (www.
phylotree.org; mtDNA tree Build 15 [September 30, 2012]). All
data analyses were carried out using MEGA 5 software (www.
megasoftware.net) to evaluate the conservation of amino acids
in mitochondria-encoded protein subunits and nucleotide
conservation in genes encoding MT-tRNA and MT-rRNA.
RESULTS
Clinical Evaluation
All eight LHON pedigrees included in this study were selected
from 187 families after confirming the m.14484T>C mutation
in the MT-ND6 gene. Detailed clinical analysis of these families
did not reveal any other abnormalities, such as neurological
disorders, hearing impairment, muscular diseases, or exercise
intolerance, which are frequently associated with mitochon-
drial dysfunctions. The most common clinical presentation in
the patients was bilateral loss of vision along with scotomas in
the visual field (central and cecocentral) and optic disc atrophy
(Fig. 1). All eight pedigrees consisted of 16 affected members
(13 males and 3 females), their mean age of onset was 23.25 6
FIGURE 1. (A) Right and (B) left eye of a 20-year-old man with the
m.14484T>C mutation in the MT-ND6 gene, presenting with bilateral
vision loss. The right eye almost appears normal, but the left eye shows
mild peripapillary nerve fiber layer (ppNFL) elevation and micro-
telengiectasia of vessels. He had bilateral centrocecal field defects.
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4.02 years, and they showed variable penetrance of the disease
(Fig. 2). The ratio of affected male versus female was 13:3,
which is higher than the earlier studies reported with the
m.14484T>C mutation. Three pedigrees (P33, P41, and P48)
had only one affected male in each, while the penetrance was
higher in P18 and P35 with more than one male member
affected by vision loss. Both male and female affected members
were seen in three pedigrees (P24, P26, and P51). Among
these pedigrees, the highest clinical presentation was observed
in P24 with three males and one female being affected. Total
penetrance was 16 out of 81 individuals (19.75%) showing
clinical phenotype of LHON and vision loss.
Genetic Analysis
Complete mtDNA was sequenced for all probands from each
family and confirmed the presence of the m.14484T>C
mutation, which was found in homoplasmic state in all the
probands and their maternal relatives who were subjected to
the analysis. The mtDNA haplogroup was constructed based
on the complete mtDNA sequences of eight probands who
carried the m.14484T>C mutation, and revealed eight different
haplogroups, namely F1c1, M31a, U2a, M*, I1, M6, M3a1, and
R30a (Fig. 3).
The occurrence of the m.14484T>C mutation in a different
haplogroup background in the present study is in complete
contrast to European pedigrees, which showed strong
association of haplogroup J with the m.14484T>C mutation.8
The effect of haplogroup on clinical expression is mostly
explained by the private nonsynonymous variations observed
in haplotypes, which influences the effect of primary
mutations and may result in variable clinical expression.10,11
We observed 22 nonsynonymous variants and four mutations
in MT-tRNA genes of the probands analyzed (Table). The
variants observed are in pedigrees P18 (m.9053G>A,
m.10398A>G, m.10609T>C, m.12406G>A, m.13759G>A,
m.13928G>C) and one MT-tRNA mutation m.10454T>C; P24
(m.8701A>G, m.10084T>C, and m.15258A>G); P26
( m . 3 3 1 6 G>A , m . 7 8 5 9 G>A , m . 1 3 7 0 8 G>A ) ; P 3 3
(m.11447G>A, m.13879T>C) ; P35 (m.9194A>G,
m.9966G>A, m.13780A>G) and one tRNA glycine mutation
m.10034T>C; P41 (m.5301A>G) and one tRNA methionine
mutation m.4418T>C; P48 (m.12842T>C); and P51
(m.4232T>C, m.5442T>C, m.8584G>A). Among these vari-
ants, three MT-tRNA variants (m.10454T>C in tRNA arginine,
m.4418T>C in tRNA methionine, and m.15931A>T in tRNA
threonine) were found to be conserved across species. In the
protein-coding region, m.4232T>C in MT-ND1 (I309T) in
pedigree P51, m.9966G>A in MT-COIII (V254I) and
m.9194G>A in MT-ATP6 (H223A) in pedigree P35, and
m.15258A>G in MT-CYB (D171G) in pedigree P24 were found
to be conserved across the species (Table).
DISCUSSION
The mtDNA mutations m.3460G>A, m.11778G>A, and
m.14484T>C have been known as the primary causes for
LHON. However, the frequency of m.14484T>C has always
been reported to be less than that of m.11778G>A in different
populations,8,15,22,34 the only exception being Canadian
population in which m.14484T>C was reported to be the
major cause for LHON.23,24 Other important characteristics of
the m.14484T>C mutation is its preferential association with
western Eurasian haplogroup J19,21 and increased clinical
penetrance when present in the J1 subhaplogroup back-
ground.10
In the present study, we found 8 out of 187 LHON
individuals carried the m.14484T>C mutation, and we
performed clinical, genetic, and molecular characterization of
these families. We sequenced the complete mtDNA of the
probands to study the matrilineal genetic structure and to look
for the potential role of specific haplotype’s association with
LHON. Painless loss of central vision was the common clinical
feature shared by all the individuals. Since all pedigrees were
homoplasmic for the m.14484T>C mutation, heteroplasmy
cannot be the reason for variable expression of the disease.
Frequency of m.14484T>C in the present study was 4.2%,
which is similar to another study (3.33%) from India,27
suggesting a much lower percentage of m.14484T>C among
Indian LHON individuals compared with European10,22 and
Chinese populations, in which the frequency was approxi-
mately 10.0%.25 However, considering the population size and
heterogeneity, more studies are required to determine the
exact frequency of this mutation in the Indian population.
Dissection of matrilineal genetic structure of patients
revealed that four out of the eight patients belonged to the
major haplogroup M (M31a, M*, M3a1, and M6); the remaining
four haplogroups were I1, F1c1, R30a, and U2a (Fig. 3).
Presence of m.14484T>C in such a diverse haplogroup
background indicated independent occurrence of this muta-
tion in different ethnic populations in India. Interestingly, we
found one family (P18) belonged to the F1c1 haplogroup,
having two out of the eight affected individuals (25%). Its
penetrance was in contrast to earlier reports from China and
FIGURE 2. Pedigrees of Indian LHON families with the m.14484T>C
mutation in the MT-ND6 gene. The affected individuals are marked
with filled symbols, and the arrow indicates the probands for whom
the complete mtDNA was sequenced.
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Thailand, which implied a protective role of this haplogroup
due to its very low occurrence.11,25,35 This haplogroup was
defined by several nonsynonymous motifs (Table) including
tRNA arginine mutation m.10454T>C, which has been
reported to influence hearing impairment when co-occurring
with the m.1555A>G mutation36 and might explain the
increased penetrance in this family, in contrast to earlier
reports.
Pedigrees P26, P35, and P51 belonged to haplogroups U2a,
I1, and R30a, respectively. It is compelling to think that the
clinical penetrance in these families should be affected by
nonsynonymous mutations present in the mtDNA background.
All three pedigrees have several nonsynonymous motifs
(Table). Pedigree P26 possessed three variants (m.3316G>A-
MT-ND1; m.7850G>A- MT-COII; and m.13708G>A- MT-ND5),
of which m.3316G>A and m.13708G>A have been found to
FIGURE 3. Phylogenetic tree constructed based on the variation in complete mtDNA sequences of eight pedigrees with the m.14484T>C mutation.
The synonymous and nonsynonymous coding-region variants are denoted by ‘‘s’’ and ‘‘ns,’’ respectively. Variations in the transfer RNA and the
ribosomal RNA genes are denoted by ‘‘t’’ and ‘‘r,’’ respectively. The insertions and deletions are denoted by ‘‘ins’’ and ‘‘del,’’ respectively, and
underlined mutations are recurrent.
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be associated with LHON.19,37 In pedigree P35, three variants
were seen (m.9194A>G- MT-ATP6; m.9966G>A- MT-COII; and
m.13780A>G- MT-ND5), of which m.9194A>G has been found
to be highly conserved and might influence the expression of
the m.14484T>C mutation in this pedigree. However, the role
of other nonsynonymous variants cannot be completely
ignored. Pedigree P51 was found to have three variants in
the protein-coding genes (m.4232T>C- MT-ND1; m.5442T>C-
MT-ND2; m.8584G>A-MT-ATP6) and one mutation
(m.15931A>T) in tRNA threonine, which might modify the
effect of m.14484T>C. Among the families falling in the macro
haplogroup M, only pedigree P24 (M31a haplogroup) pos-
sessed the highest clinical penetrance out of eight pedigrees
(34%). Three nonsynonymous variants (m.8701A>G- MT-ATP6;
m.10084T>C- MT-ND3; and m.15258A>G- MT-CYB) have been
observed in this pedigree. Of these m.8701A>G has been
reported to alter mitochondrial matrix Ph and intracellular
calcium dynamics.38 Additional MT-CYB motifs on the J
haplogroup is reported to be one of the main reasons for their
association and increased clinical expression,10 and hence it is
plausible that the additional variant m.15258A>G, which
changes highly conserved aspartic acid to glycine in cyto-
chrome b, might influence the severity of disease expression in
this pedigree.
The main interesting observation in this study was the
existence of the pathogenic mutation m.14484T>C in different
haplogroup backgrounds. This is in fact not surprising to us
because we have demonstrated that India is not inhabited by a
single large population, but rather by a large number of small
populations that have been maintaining strict endogamy
marriage practices over tens of thousands of years.39–41
Moreover, the finding that four out of eight patients with
haplogroup M can be explained by the existence of high
frequency of M haplogroup in India.40 We have also
demonstrated that the genetic etiology of various diseases is
unique to Indian populations.28,42 Hence, it would be
interesting to see the effect of Indian haplogroups on the
LHON-causing m.14484T>C mutation.
This is the first detailed report about the m.14484T>C
mutation and its haplogroup association in the Indian
population. The distinct set of sequence variations observed
in these Indian pedigrees points toward m.14484T>C arising
independently in different mitochondrial haplogroup back-
grounds in the Indian population. Further, our study explains
that there is no association of any specific haplogroup with the
m.14484T>C mutation. This is in complete contrast to
European pedigrees, which show a strong association of
haplogroup J. However, considering the small sample size,
more LOHN samples with m.14484T>C mutations need to be
analyzed to support our findings. We observed differential
penetrance of LHON against different Indian haplogroup
backgrounds, thus indicating their possible influence on the
TABLE. Private Nonsynonymous and MT-tRNA Variants in Indian LHON Families With m.14484T>C Mutation
Subjects Haplogroup Ethnicity
Nucleotide
Position rCRS
Base
Change Gene Position
Amino
Acid
Change Conservation Reported
P18 F1c1 West Bengal 9053 G A MT-ATPase6 176 Ser>Asn No Yes
10454 T C MT-tRNA Arg — — Yes Yes
10398 A G MT-ND3 114 Thr>Ala No Yes
10609 T C MT-ND4L 47 Met>Thr No Yes
12406 G A MT-ND5 24 Val>Ile No Yes
13759 G A MT-ND5 475 Ala>Thr No Yes
13928 G C MT-ND5 531 Ser>Thr No Yes
P24 M31a West Bengal 8701 A G MT-ATPase6 59 Thr>Ala No Yes
10084 T C MT-ND3 9 Ile>Thr No Yes
15258 A G MT-Cytb 171 Asp>Gly Yes Yes
P26 U2a Madhya Pradesh 3316 G A MT-ND1 4 Ala>Thr No Yes
7859 G A MT-COII 92 Asp>Asn No Yes
13708 G A MT-ND5 458 Ala>Thr No Yes
P33 M* Tamil Nadu 11447 G A MT-ND4 230 Val>Met No Yes
13879 T C MT-ND5 515 Ser>Pro No Yes
P35 I1 Bihar 9194 A G MT-ATPase6 223 His>Arg Yes Yes
9966 G A MT-COIII 254 Val>Ile Yes Yes
10034 T C MT-tRNA Gly — — No Yes
13780 A G MT-ND5 482 Ile>Val No Yes
P41 M6 Tamil Nadu 4418 T C MT-tRNA Met — — Yes Yes
5301 A G MT-ND2 278 Ile>Val No Yes
P48 M3a1 Uttar Pradesh 12842 T C MT-ND5 169 Ile>Thr No Yes
P51 R30a Andhra Pradesh 4232 T C MT-ND1 309 Ile>Thr Yes Yes
5442 T C MT-ND2 325 Phe>Leu No Yes
8584 G A MT-ATPase6 20 Ala>Thr No Yes
15931 A T MT-tRNA Thr — — Yes No
The conservation analysis was performed by comparing human mtDNA sequence with 21 different species (rCRS NC_012920, Mus musculus
NC_005089, Rattus norvegicus NC_001665, Bos taurus NC_006853, Danio rerio NC_002333, Macaca mulatta NC_005943, Canis lupus familiaris
NC_002008, Felis catus NC_001700, Equus caballus NC_001640, Cavia porcellus NC_000884, Pan troglodytes NC_001643, Sus scrofa NC_000845,
Oryctolagus cuniculus NC_001913, Capra hircus NC_005044, Camelus dromedarius NC_009849, Panthera tigris NC_010642, Elephas maximus
NC_005129, Cervus elaphus NC_007704, Canis lupus NC_008092, Giraffa camelopardalis NC_012100, Bufo gargarizans NC_008410, Delphinus
capensis NC_012061).
Haplogroup Heterogeneity of LHON Patients IOVS j June 2013 j Vol. 54 j No. 6 j 4003
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933468/ on 05/16/2017
clinical expression of disease. However, further studies on
more patients are required for new insights about the
m.14484T>C mutation and its haplogroup association with
LHON in the Indian population.
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